01.14.15
Medrobotics Corp. has released its Flex Retractor in the United States and Europe.
The Flex Retractor is lightweight and, according to the company, easy to handle and position. It has been designed to improve exposure in advanced transoral surgeries, including robotic and laser microsurgery procedures. Medrobotics has incorporated an industry first axial tongue blade rotation capability, which allows surgeons to create unprecedented exposure in certain procedures involving the base of tongue, bigwigs noted in a news release.
“The Flex Retractor is a significant advance for transoral surgery. With its adjustability and ease of use, the Flex Retractor offers head and neck surgeons the confidence that they can efficiently achieve the exposure that they need for advanced transoral procedures,” said Marshall Strome, M.D., professor and chairman emeritus, Cleveland Clinic Head and Neck Institute and co-chair of Medrobotics' Medical Advisory Board.
Minimally invasive surgery has demonstrated advantages for patients and providers compared to traditional open procedures, decreasing hospital stays and recovery times. The Flex System was designed to provide an affordable, easy-to-use computer-assisted surgical platform for hospitals and surgeons seeking to provide minimally-invasive treatment options to the broadest number of patients, executives said.
Medrobotics received the CE mark for the Flex Retractor which permits distribution in the European Union. In America, the product is considered a class I device and therefore is exempt from the U.S. Food and Drug Administration's premarket notification process; however, it has not been cleared for sale in the United States.
Medrobotics Corporation is a privately-held company headquartered in Raynham, Mass., that manufactures and markets the Flex System, a computer-assisted platform that provides surgeons with single-site access and visualization of hard-to-reach anatomical locations.
The Flex Retractor is lightweight and, according to the company, easy to handle and position. It has been designed to improve exposure in advanced transoral surgeries, including robotic and laser microsurgery procedures. Medrobotics has incorporated an industry first axial tongue blade rotation capability, which allows surgeons to create unprecedented exposure in certain procedures involving the base of tongue, bigwigs noted in a news release.
“The Flex Retractor is a significant advance for transoral surgery. With its adjustability and ease of use, the Flex Retractor offers head and neck surgeons the confidence that they can efficiently achieve the exposure that they need for advanced transoral procedures,” said Marshall Strome, M.D., professor and chairman emeritus, Cleveland Clinic Head and Neck Institute and co-chair of Medrobotics' Medical Advisory Board.
Minimally invasive surgery has demonstrated advantages for patients and providers compared to traditional open procedures, decreasing hospital stays and recovery times. The Flex System was designed to provide an affordable, easy-to-use computer-assisted surgical platform for hospitals and surgeons seeking to provide minimally-invasive treatment options to the broadest number of patients, executives said.
Medrobotics received the CE mark for the Flex Retractor which permits distribution in the European Union. In America, the product is considered a class I device and therefore is exempt from the U.S. Food and Drug Administration's premarket notification process; however, it has not been cleared for sale in the United States.
Medrobotics Corporation is a privately-held company headquartered in Raynham, Mass., that manufactures and markets the Flex System, a computer-assisted platform that provides surgeons with single-site access and visualization of hard-to-reach anatomical locations.